ABL1-mediated tyrosine phosphorylation of SYCP2 contributes to transcription-coupled homologous recombination and platinum resistance in ovarian cancer.
Saved in:
| Title: | ABL1-mediated tyrosine phosphorylation of SYCP2 contributes to transcription-coupled homologous recombination and platinum resistance in ovarian cancer. |
|---|---|
| Authors: | Gao B; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Wang X; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Long M; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Zhang F; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Wang Y; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States., Kumar R; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States., Veillard I; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States., Rueda BR; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, United States.; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States., Yeku O; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States., Lan L; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States. |
| Source: | NAR cancer [NAR Cancer] 2025 Sep 03; Vol. 7 (3), pp. zcaf031. Date of Electronic Publication: 2025 Sep 03 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101769553 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8674 (Electronic) Linking ISSN: 26328674 NLM ISO Abbreviation: NAR Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40918650 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: ABL1-mediated tyrosine phosphorylation of SYCP2 contributes to transcription-coupled homologous recombination and platinum resistance in ovarian cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gao+B%22">Gao B</searchLink>; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States.<br /><searchLink fieldCode="AU" term="%22Long+M%22">Long M</searchLink>; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States.<br /><searchLink fieldCode="AU" term="%22Zhang+F%22">Zhang F</searchLink>; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States.<br /><searchLink fieldCode="AU" term="%22Kumar+R%22">Kumar R</searchLink>; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Veillard+I%22">Veillard I</searchLink>; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Rueda+BR%22">Rueda BR</searchLink>; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, United States.; Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Yeku+O%22">Yeku O</searchLink>; Division of Hematology-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.; Department of Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States.<br /><searchLink fieldCode="AU" term="%22Lan+L%22">Lan L</searchLink>; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, 213 Research Drive, Durham, NC 27710, United States.; Massachusetts General Hospital Cancer Center, Harvard Medical School, 13th Street, Charlestown, MA 02129, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101769553%22">NAR cancer</searchLink> [NAR Cancer] 2025 Sep 03; Vol. 7 (3), pp. zcaf031. <i>Date of Electronic Publication: </i>2025 Sep 03 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101769553 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-8674 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226328674%22">26328674 </searchLink><i>NLM ISO Abbreviation: </i>NAR Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40918650 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/narcan/zcaf031 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: zcaf031 Titles: – TitleFull: ABL1-mediated tyrosine phosphorylation of SYCP2 contributes to transcription-coupled homologous recombination and platinum resistance in ovarian cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gao B – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Long M – PersonEntity: Name: NameFull: Zhang F – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Kumar R – PersonEntity: Name: NameFull: Veillard I – PersonEntity: Name: NameFull: Rueda BR – PersonEntity: Name: NameFull: Yeku O – PersonEntity: Name: NameFull: Lan L IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 09 Text: 2025 Sep 03 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2632-8674 Numbering: – Type: volume Value: 7 – Type: issue Value: 3 Titles: – TitleFull: NAR cancer Type: main |
| ResultId | 1 |